Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Received: 2 November 2021
Revised: 25 March 2022
Accepted: 22 April 2022
First Online: 1 June 2022
Declarations
:
: Jason P. Weinman is on the advisory board and receives non-financial support in the study of fibrosing lung disease from Boehringer Ingelheim Inc., and is a reviewer for fibrosing lung disease for Parexel/Calyx. The other authors have nothing to disclose.
